| Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease V Brochard, B Combadière, A Prigent, Y Laouar, A Perrin, V Beray-Berthat, ... The Journal of clinical investigation 119 (1), 2008 | 1268 | 2008 |
| Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension JM Launay, P Herve, K Peoc'h, C Tournois, J Callebert, CG Nebigil, ... Nature medicine 8 (10), 1129-1135, 2002 | 546 | 2002 |
| Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease T Breidert, J Callebert, MT Heneka, G Landreth, JM Launay, EC Hirsch Journal of neurochemistry 82 (3), 615-624, 2002 | 491 | 2002 |
| Bilirubin decreases nos2 expression via inhibition of NAD (P) H oxidase: implications for protection against endotoxic shock in rats S Lanone, S Bloc, R Foresti, A Almolki, C Taillé, J Callebert, M Conti, ... The FASEB Journal 19 (13), 1890-1892, 2005 | 339 | 2005 |
| Genetic deficiency of indoleamine 2, 3-dioxygenase promotes gut microbiota-mediated metabolic health L Laurans, N Venteclef, Y Haddad, M Chajadine, F Alzaid, S Metghalchi, ... Nature medicine 24 (8), 1113-1120, 2018 | 223 | 2018 |
| Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia A Buisson, I Margaill, J Callebert, M Plotkine, RG Boulu Journal of neurochemistry 61 (2), 690-696, 1993 | 220 | 1993 |
| High plasma serotonin levels in primary pulmonary hypertension: effect of long-term epoprostenol (prostacyclin) therapy A Kereveur, J Callebert, M Humbert, P Herve, G Simonneau, JM Launay, ... Arteriosclerosis, thrombosis, and vascular biology 20 (10), 2233-2239, 2000 | 174 | 2000 |
| Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy F Jaffré, P Bonnin, J Callebert, H Debbabi, V Setola, S Doly, L Monassier, ... Circulation research 104 (1), 113-123, 2009 | 168 | 2009 |
| Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1β, and Tumor … F Jaffré, J Callebert, A Sarre, N Etienne, CG Nebigil, JM Launay, ... Circulation 110 (8), 969-974, 2004 | 168 | 2004 |
| Modulation of Fgfr1a signaling in zebrafish reveals a genetic basis for the aggression–boldness syndrome WHJ Norton, K Stumpenhorst, T Faus-Kessler, A Folchert, N Rohner, ... Journal of Neuroscience 31 (39), 13796-13807, 2011 | 167 | 2011 |
| Embryonic depletion of serotonin affects cortical development T Vitalis, O Cases, S Passemard, J Callebert, JG Parnavelas European Journal of Neuroscience 26 (2), 331-344, 2007 | 167 | 2007 |
| Ras Involvement in Signal Transduction by the Serotonin 5-HT2B Receptor (∗) JM Launay, G Birraux, D Bondoux, J Callebert, DS Choi, S Loric, ... Journal of Biological Chemistry 271 (6), 3141-3147, 1996 | 165 | 1996 |
| Decreased osteoclastogenesis in serotonin-deficient mice Y Chabbi-Achengli, AE Coudert, J Callebert, V Geoffroy, F Côté, C Collet, ... Proceedings of the National Academy of Sciences 109 (7), 2567-2572, 2012 | 157 | 2012 |
| Serotonin 5-HT2B receptors are required for 3, 4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro S Doly, E Valjent, V Setola, J Callebert, D Hervé, JM Launay, L Maroteaux Journal of Neuroscience 28 (11), 2933-2940, 2008 | 156 | 2008 |
| Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period T Vitalis, O Cases, J Callebert, JM Launay, DJ Price, I Seif, P Gaspar Journal of Comparative Neurology 393 (2), 169-184, 1998 | 156 | 1998 |
| Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation JM Launay, M Del Pino, G Chironi, J Callebert, K Peoc'h, JL Mégnien, ... PloS one 4 (11), e7959, 2009 | 152 | 2009 |
| PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor P Manivet, S Mouillet-Richard, J Callebert, CG Nebigil, L Maroteaux, ... Journal of Biological Chemistry 275 (13), 9324-9331, 2000 | 151 | 2000 |
| The serotonin-N-acetylserotonin–melatonin pathway as a biomarker for autism spectrum disorders C Pagan, R Delorme, J Callebert, H Goubran-Botros, F Amsellem, ... Translational psychiatry 4 (11), e479-e479, 2014 | 149 | 2014 |
| Monosodium urate monohydrate crystal–induced inflammation in vivo: quantitative histomorphometric analysis of cellular events C Schiltz, F Lioté, F Prudhommeaux, A Meunier, R Champy, J Callebert, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 137 | 2002 |
| Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice E Rousselet, C Joubert, J Callebert, K Parain, L Tremblay, G Orieux, ... Neurobiology of disease 14 (2), 218-228, 2003 | 131 | 2003 |
